Interferon alfa-2A and ribavirin therapy for hepatitis C recurrence after liver transplantation

被引：8
|
作者：
Wietzke, P
Braun, F
Ringe, B
Ramadori, G
机构：
[1] Univ Gottingen, Abt Gastroenterol & Endokrinol, D-37075 Gottingen, Germany
[2] Univ Gottingen, Klin Transplantat Chirurg, D-37075 Gottingen, Germany
来源：
TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 07期
关键词：
D O I：
10.1016/S0041-1345(00)01782-6
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：2539 / 2542
页数：4
相关论文
共 50 条
  • [21] Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    Chung, RT
    Andersen, J
    Volberding, P
    Robbins, GK
    Liu, T
    Sherman, KE
    Peters, MG
    Koziel, MJ
    Bhan, AK
    Alston, B
    Colquhoun, D
    Nevin, T
    Harb, G
    van der Horst, C
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 451 - 459
  • [22] Interferon alfa-2a in combination with ribavirin and amantadine (triple therapy) in hepatitis C patients with previous non-response or relapse to interferon alfa and ribavirin combination therapy.
    Reichard, O
    Lindahl, K
    Schvarcz, R
    Uhnoo, I
    Shev, S
    Carlsson, T
    Wejstal, R
    HEPATOLOGY, 1999, 30 (04) : 372A - 372A
  • [23] Ribavirin/interferon-alfa sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra, E
    Kullak-Ublick, G
    Keller, W
    Fried, R
    Kraehenbuhl, S
    Vanlemmens, C
    Egger, HP
    Clavien, P
    Mentha, G
    Morel, P
    Hadengue, A
    Negro, F
    HEPATOLOGY, 2001, 34 (04) : 641A - 641A
  • [24] An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation
    Nikroo Hashemi
    Victor Araya
    Kashif Tufail
    Laxmi Thummalakunta
    Eyob Feyssa
    Ashaur Azhar
    Mumtaz Niazi
    Jorge Ortiz
    World Journal of Hepatology, 2011, 3 (07) : 198 - 204
  • [25] An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation
    Hashemi, Nikroo
    Araya, Victor
    Tufail, Kashif
    Thummalakunta, Laxmi
    Feyssa, Eyob
    Azhar, Ashaur
    Niazi, Mumtaz
    Ortiz, Jorge
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (07) : 198 - 204
  • [26] Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin
    Gopal, DV
    Rabkin, JM
    Berk, BS
    Corless, CL
    Chou, SW
    Olyaei, A
    Orloff, SL
    Rosen, HR
    LIVER TRANSPLANTATION, 2001, 7 (03) : 181 - 190
  • [27] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4
    El Makhzangy, Hesham
    Esmat, Gamal
    Said, Mohamed
    ElRaziky, Maissa
    Shouman, Soheir
    Refai, Rasha
    Rekacewicz, Claire
    Gad, Rita Raafat
    Vignier, Nicolas
    Abdel-Hamid, Mohamed
    Zalata, Khaled
    Bedossa, Pierre
    Pol, Stanislas
    Fontanet, Arnaud
    Mohamed, Mostafa K.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583
  • [28] Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, J
    Weaver, L
    Schafer, DF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 3042 - 3044
  • [29] Interferon/ribavirin combination therapy in patients with hepatitis C, reactivation after liver transplantation
    Zachoval, R
    Schirren, CA
    Mathias, B
    Diepolder, HM
    Gerlach, JT
    Gruener, N
    Jung, MC
    Pape, GR
    JOURNAL OF HEPATOLOGY, 2001, 34 : 34 - 34
  • [30] Randomized controlled trial of combination therapy with interferon (IFN) ALFA-2A and ribavirin, in patients with chronic hepatitis C who relapsed after interferon therapy.
    Marcellin, P
    Hezode, C
    Castelnau, C
    Barange, K
    Couzigou, P
    Larrey, D
    Rosmorduc, O
    Tran, A
    Martinot, M
    Degott, C
    Saint-Marc girardin, MF
    HEPATOLOGY, 1999, 30 (04) : 192A - 192A
12345